About Hetero
Hetero is a company based in Hyderabad (India) founded in 1993. It operates as a B2B2C and Reseller / Distribution. The company has 7,319 employees as of November 20, 2024. Hetero has completed 1 acquisition, including Tarbis Farma. Hetero offers products and services including APIs, Global Generics, Biosimilars, and Custom Pharmaceutical Services. Hetero operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
- Headquarter Hyderabad, India
- Employees 7319 as on 20 Nov, 2024
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Hetero Labs Limited
- Jurisdiction Balanagar, Telangana, India
-
Annual Revenue
$1.66 B (USD)14.54as on Mar 31, 2023
-
Net Profit
$148.76 M (USD)22.29as on Mar 31, 2023
-
EBITDA
$267.67 M (USD)28.6as on Mar 31, 2023
-
Latest Funding Round
-
Investors
-
Employee Count
7319
as on Nov 20, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Hetero
Hetero offers a comprehensive portfolio of products and services, including APIs, Global Generics, Biosimilars, and Custom Pharmaceutical Services.
Active pharmaceutical ingredients are developed for global markets.
Generic drugs are produced for chronic therapy areas.
Biosimilar products are created for sustainable health equity.
Integrated services are offered across the value chain.
People of Hetero
Unlock access to complete
Funding Insights of Hetero
Investments & Acquisitions by Hetero
Hetero has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Tarbis Farma.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Generic and other drugs are manufactured by Tarbis Farma.
|
0 |
Financial Statements - Hetero
Hetero Comparisons
Competitors of Hetero
Hetero operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for the treatment of multiple disorders
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
Latest news on Hetero
Frequently Asked Questions about Hetero
Hetero was founded in 1993.
Hetero is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Nov 20, 2024, the latest employee count at Hetero is 7,319.
Annual revenue of Hetero is $1.66B as on Mar 31, 2023.
Hetero is established as a prominent pharmaceutical company headquartered in Hyderabad, India. Operations are focused on the development and manufacturing of active pharmaceutical ingredients (APIs), global generics, biosimilars, and custom pharmaceutical services. A strong emphasis is placed on research and development to address unmet medical needs. Products are distributed across over 145 countries, supported by 36 state-of-the-art manufacturing facilities. Efforts are made to ensure affordability and accessibility of life-saving medicines worldwide. Partnerships with multinational companies and global agencies are maintained to enhance healthcare standards. Additionally, a commitment to sustainability and community welfare is integrated into the business practices.
Hetero's top competitors include Merck, Roivant Sciences and AbbVie.
Hetero offers APIs, Global Generics, Biosimilars, and Custom Pharmaceutical Services.
Hetero has made 1 acquisition, including Tarbis Farma.